Baiyunshan Pharma's H1 Profit Slips 1%, Revenue Rises 2%; Hong Kong Shares Up 4%
MT Newswires Live
Aug 18
Guangzhou Baiyunshan Pharmaceutical Holdings' (SHA:600332, HKG:0874) net profit attributable to the shareholders in the first half slipped 1.3% year on year to 2.52 billion yuan, or 1.548 yuan per share, according to a Hong Kong disclosure on Saturday.
The Chinese pharmaceutical company's Hong Kong shares jumped over 4%, and Shanghai shares rose less than 3%.
The attributable profit a year earlier was 2.55 billion yuan, or 1.568 yuan per share.
The operating revenue rose 1.9% to 41.8 billion yuan from 41 billion yuan in the previous year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.